Diabetes mellitus in rheumatic diseases: clinical characteristics and treatment considerations
Y Fedorchenko, K Mahmudov, Z Abenov… - Rheumatology …, 2023 - Springer
New pathophysiological insights are now available on comorbidities in rheumatic diseases
(RDs). Several nationwide studies point to the fact that comorbid diabetes mellitus (DM) …
(RDs). Several nationwide studies point to the fact that comorbid diabetes mellitus (DM) …
[HTML][HTML] Immune system effects on the endocrine system
M Tsoli, G Boutzios, G Kaltsas - 2015 - europepmc.org
Among the most important and complex systems in the human body are the endocrine and
immune systems. Emerging research over the last decade has shed light on their …
immune systems. Emerging research over the last decade has shed light on their …
[HTML][HTML] N-Acetylcysteine overcomes epalrestat-mediated increase of toxic 4-hydroxy-2-nonenal and potentiates the anti-arthritic effect of epalrestat in AIA model
L Wang, B Huang, Y Zeng, J Yang, Z Li… - … Journal of Biological …, 2023 - ncbi.nlm.nih.gov
Epalrestat, an aldose reductase inhibitor (ARI), has been clinically adopted in treating
diabetic neuropathy in China and Japan. Apart from the involvement in diabetic …
diabetic neuropathy in China and Japan. Apart from the involvement in diabetic …
The effects of suppressing inflammation by tofacitinib may simultaneously improve glycaemic parameters and inflammatory markers in rheumatoid arthritis patients …
C Di Muzio, I Di Cola, A Shariat Panahi, F Ursini… - Arthritis Research & …, 2024 - Springer
Background A consistent connection has been increasingly reported between rheumatoid
arthritis (RA), insulin resistance (IR), and type 2 diabetes (T2D). The β-cell apoptosis …
arthritis (RA), insulin resistance (IR), and type 2 diabetes (T2D). The β-cell apoptosis …
Interleukin-19 promotes bone resorption by suppressing osteoprotegerin expression in BMSCs in a lipopolysaccharide-induced bone loss mouse model
Z Dai, Y Chen, E He, H Wang, W Guo… - Bone & Joint …, 2023 - boneandjoint.org.uk
Aims Osteoporosis is characterized by decreased trabecular bone volume, and
microarchitectural deterioration in the medullary cavity. Interleukin-19 (IL-19), a member of …
microarchitectural deterioration in the medullary cavity. Interleukin-19 (IL-19), a member of …
Tofacitinib may improve insulin resistance in patients with rheumatoid arthritis and diabetes, implications for disease management and precision medicine approach
C Di Muzio, F Ursini, A Iagnocco… - Autoimmunity …, 2023 - pubmed.ncbi.nlm.nih.gov
Tofacitinib may improve insulin resistance in patients with rheumatoid arthritis and diabetes,
implications for disease management and precision medicine approach Tofacitinib may …
implications for disease management and precision medicine approach Tofacitinib may …
[HTML][HTML] Применение метотрексата при ревматоидном артрите. Рекомендации Общероссийской общественной организации «Ассоциация ревматологов …
ЕЛ Насонов, ВН Амирджанова… - Научно …, 2023 - cyberleninka.ru
Ревматоидный артрит (РА)-наиболее частое иммуновоспалительное (аутоиммунное)
ревматическое заболевание, характеризующееся хроническим эрозивным артритом и …
ревматическое заболевание, характеризующееся хроническим эрозивным артритом и …
Скелетно-мышечные нарушения при сахарном диабете
ЕА Балахонова - Сахарный диабет, 2023 - dia-endojournals.ru
Аннотация Повышенная распространенность скелетно-мышечных заболеваний
наиболее часто отмечается при сахарном диабете (СД) по сравнению с населением в …
наиболее часто отмечается при сахарном диабете (СД) по сравнению с населением в …
Differential Causal Effects of Type 1 and Type 2 Diabetes on Osteomyelitis Risk: Insights from Mendelian Randomization Analysis
YH Li Sr, C Zhou Jr, L Yang Sr, L Tan Sr - medRxiv, 2024 - medrxiv.org
Background: Osteomyelitis (OM) poses a significant clinical challenge, especially among
individuals with diabetes mellitus (DM). While both type 1 diabetes mellitus (T1DM) and type …
individuals with diabetes mellitus (DM). While both type 1 diabetes mellitus (T1DM) and type …
Musculoskeletal disorders in diabetes mellitus
EA Balakhonova - Diabetes mellitus, 2023 - dia-endojournals.ru
The increased prevalence of musculoskeletal diseases is most often observed in diabetes
mellitus (DM) compared to the general population. This is a common cause of disability. DM …
mellitus (DM) compared to the general population. This is a common cause of disability. DM …